>
COMMANDS Global: GP Symbol: IBM FA
↑↓ Navigate Enter Open Esc Close ` Toggle
Articles > ABSI, PCT, CRSP, CRH, JPM showing five-day upward surge

ABSI, PCT, CRSP, CRH, JPM showing five-day upward surge

By KlickAnalytics Data Insights  |   February 18, 2025 10:42AM ET

Absci Corporation (ABSI)

ABSI is trading UP for the last 5 days, and it at trading at $6.15 with volume of 5,155,234 and a one day change of $0.33 (5.67%). Absci Corporation has a 52-week low of 2.58 and a 52-week high of $6.72. The business's 50-day moving average price is $3.57 and its 200 day moving average price is $3.88. The firm has a market cap of $1 million, a P/E ratio of 0.00, and a beta of 2.13.

Top news headlines for ABSI

  • VANCOUVER, Wash. and NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the upcoming TD Cowen 45th Annual Health Care Conference in Boston, MA.

  • For more information on ABSI:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • PureCycle Technologies, Inc. (PCT)

    PCT is trading UP for the last 5 days, and it at trading at $10.80 with volume of 2,774,807 and a one day change of $1.49 (16.00%). PureCycle Technologies, Inc. has a 52-week low of 4.60 and a 52-week high of $15.58. The business's 50-day moving average price is $10.33 and its 200 day moving average price is $8.41. The firm has a market cap of $2 million, a P/E ratio of 0.00, and a beta of 1.62.

    For more information on PCT:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • CRISPR Therapeutics AG (CRSP)

    CRSP is trading UP for the last 5 days, and it at trading at $53.78 with volume of 2,753,604 and a one day change of $4.06 (8.16%). CRISPR Therapeutics AG has a 52-week low of 39.00 and a 52-week high of $91.10. The business's 50-day moving average price is $42.73 and its 200 day moving average price is $49.52. The firm has a market cap of $4 million, a P/E ratio of 14.17, and a beta of 1.67.

    Top news headlines for CRSP

  • The rise in CRISPR Therapeutics' share price can be attributed to the better-than-expected Q4 results and a rating upgrade by a well-established financial services firm.

  • For more information on CRSP:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • CRH plc (CRH)

    CRH is trading UP for the last 5 days, and it at trading at $109.79 with volume of 1,780,918 and a one day change of $1.49 (1.37%). CRH plc has a 52-week low of 70.87 and a 52-week high of $108.39. The business's 50-day moving average price is $98.00 and its 200 day moving average price is $88.68. The firm has a market cap of $74 million, a P/E ratio of 18.45, and a beta of 1.38.

    For more information on CRH:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • JPMorgan Chase & Co. (JPM)

    JPM is trading UP for the last 5 days, and it at trading at $278.21 with volume of 1,755,495 and a one day change of $1.62 (0.58%). JPMorgan Chase & Co. has a 52-week low of 171.16 and a 52-week high of $279.23. The business's 50-day moving average price is $252.41 and its 200 day moving average price is $220.68. The firm has a market cap of $779 million, a P/E ratio of 11.99, and a beta of 1.11.

    Top news headlines for JPM

  • NEW YORK , Feb. 18, 2025 /PRNewswire/ -- J.P. Morgan Asset Management has announced plans to convert the JPMorgan Unconstrained Debt Fund, pending board approval in May 2025.

  • For more information on JPM:
  • Historical Price Targets
  • Hiistorical Analyst Recommendations
  • Earning Price Impact Analysis
  • Seasonality Analysis

  • This article was generated by KlickAnalytics data insight content engine.

    Disclaimer: the above is a summary showing certain market information. KlickAnalytics is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from various resources and more. Communications displaying market prices, data and other information available in this post are meant for purely for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.

    Market News ×
    Loading news…